| Literature DB >> 29198933 |
Antonio I Cuesta-Vargas1, Randy Neblett2, Alessandro Chiarotto3, Jeroen Kregel4, Jo Nijs5, C Paul van Wilgen6, Laurent Pitance7, Aleksandar Knezevic8, Robert J Gatchel9, Tom G Mayer10, Carlotta Viti11, Cristina Roldan-Jiménez12, Marco Testa13, Wolnei Caumo14, Milica Jeremic-Knezevic15, Juan V Luciano16.
Abstract
Central sensitization (CS) involves the amplification of neural signaling within the central nervous system, which evokes pain hypersensitivity. The Central Sensitization Inventory (CSI) assesses 25 overlapping health-related symptom dimensions that have been reported to be associated with CS-related disorders. Previous studies have reported satisfactory test-retest reliability and internal consistency, but factor analyses have exhibited conflicting results in different language versions. The purpose of this cross-sectional study was to thoroughly examine the dimensionality and reliability of the CSI, with pooled data from 1,987 individuals, collected in several countries. The principal component analysis suggested that 1 general factor of CS best described the structure. A subsequent confirmatory factor analysis revealed that a bifactor model, which accounted for the covariance among CSI items, with regard to 1 general factor and 4 orthogonal factors, fit the CSI structure better than the unidimensional and the 4-factor models. Additional analyses indicated substantial reliability for the general factor (ie, Cronbach α = .92; ω = .95; and ω hierarchical = .89). Reliability results for the 4 specific factors were considered too low to be used for subscales. The results of this study clearly suggest that only total CSI scores should be used and reported. PERSPECTIVE: As far as we know, this is the first study that has examined the factor structure and reliability of the CSI in a large multicountry sample. The CSI is currently considered the leading self-report measure of CS-related symptoms worldwide.Entities:
Keywords: Central Sensitization Inventory; central sensitivity syndrome, chronic pain, psychometrics; central sensitization; multicountry sample
Mesh:
Year: 2017 PMID: 29198933 DOI: 10.1016/j.jpain.2017.11.006
Source DB: PubMed Journal: J Pain ISSN: 1526-5900 Impact factor: 5.820